• SPX
  • 6090.27
  • 0.25 %
  • 15.1602
  • DJI
  • 44642.52
  • -0.28 %
  • -123.1914
  • N225
  • 39091.17
  • -0.77 %
  • -304.4297
  • FTSE
  • 8308.61
  • -0.49 %
  • -40.7695
  • IXIC
  • 19859.773
  • 0.81 %
  • 159.0508
Integra LifeSciences Holdings Corporation (IART) Stock Price, News & Analysis

Integra LifeSciences Holdings Corporation (IART) Stock Price, News & Analysis

Currency in USD Disclaimer

$24.09

$0.23

(0.96%)

Day's range
$23.83
Day's range
$24.33
50-day range
$16.81
Day's range
$26.96
  • Country: US
  • ISIN: US4579852082
52 wk range
$16.81
Day's range
$45.42


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 1.28
  • Piotroski Score 4.00
  • Grade Sell
  • Symbol (IART)
  • Company Integra LifeSciences Holdings Corporation
  • Price $24.09
  • Changes Percentage (0.96%)
  • Change $0.23
  • Day Low $23.83
  • Day High $24.33
  • Year High $45.42

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 02/26/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $23.00
  • High Stock Price Target $26.00
  • Low Stock Price Target $20.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $0.51
  • Trailing P/E Ratio 60.39
  • Forward P/E Ratio 60.39
  • P/E Growth 60.39
  • Net Income $67.74 M

Income Statement

Quarterly

Annual

Latest News of IART

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Integra LifeSciences Holdings Corporation Frequently Asked Questions

  • What were the earnings of IART in the last quarter?

    In the last quarter Integra LifeSciences Holdings Corporation earnings were on Monday, November, 4th. The Integra LifeSciences Holdings Corporation maker reported $0.41 EPS for the quarter, beating analysts' consensus estimates of $0.39 by $0.02.

  • What is the Integra LifeSciences Holdings Corporation stock price today?

    Today's price of Integra LifeSciences Holdings Corporation is $24.09 — it has increased by +0.96% in the past 24 hours. Watch Integra LifeSciences Holdings Corporation stock price performance more closely on the chart.

  • Does Integra LifeSciences Holdings Corporation release reports?

    Yes, you can track Integra LifeSciences Holdings Corporation's financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Integra LifeSciences Holdings Corporation stock forecast?

    Watch the Integra LifeSciences Holdings Corporation chart and read a more detailed Integra LifeSciences Holdings Corporation stock forecast to see what analysts suggest you do with its shares.

  • What is Integra LifeSciences Holdings Corporation stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Integra LifeSciences Holdings Corporation stock ticker.

  • How to buy Integra LifeSciences Holdings Corporation stocks?

    Like other stocks, IART shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Integra LifeSciences Holdings Corporation's EBITDA?

    Integra LifeSciences Holdings Corporation measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Integra LifeSciences Holdings Corporation’s financial statements.

  • What is the Integra LifeSciences Holdings Corporation's net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0.0439427779, which equates to approximately 4.39%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Integra LifeSciences Holdings Corporation stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Integra LifeSciences Holdings Corporation's financials relevant news, and technical analysis. Integra LifeSciences Holdings Corporation's technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Integra LifeSciences Holdings Corporation stock currently indicates a “sell” signal. For more insights, review Integra LifeSciences Holdings Corporation’s technical analysis.

  • A revenue figure for Integra LifeSciences Holdings Corporation for its last quarter?

    Integra LifeSciences Holdings Corporation published it's last quarterly revenues at $380.83 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.